AR-ACXIOM
GlobeOne ®, LLC, a financial technology company collaborating with a network of financial institutions around the world, has selected Acxiom ® (Nasdaq: ACXM), an enterprise data, analytics and software-as-a-service company to develop a database and processing platform to collect, process, calculate and return data to partner banks in the GlobeOne network.
GlobeOne, founded by a community of socially conscious entrepreneurs with experience in the financially underserved markets, is committed to enhancing financial inclusion, a critical element for economic and social development. By pioneering the use of technology to make financial transactions affordable and flexible, and activating its network of member banks, GlobalOne creates financial opportunities and community growth.
As part of this multi-year agreement, Acxiom will provide data hosting services to help GlobeOne to collect, process, calculate and return data to partner banks in the GlobeOne network. As a trusted extension of GlobeOne, Acxiom will adhere to the Fair Credit Reporting Act (FCRA) and the Gramm–Leach–Bliley Act (GLBA) that regulates the collection and use of consumers’ financial data.
“We firmly believe that everyone benefits from financial inclusion,” said Stephen Landry, chief operating officer at GlobeOne. “Our partnership with Acxiom will help us advance our vision of transforming the lives of the communities in which we operate – we were impressed by the speed, scalability and cost-effectiveness of Acxiom’s solution.”
“We are honored to support GlobeOne as they strive to create opportunities for the underserved markets,” said Jim Harold, group vice president at Acxiom. “We look forward to working with progressive financial services entities like GlobeOne to drive innovation and create greater customer value.”
About GlobeOne
Headquartered in Santa Monica, CA, GlobeOne LLC is a financial technology company collaborating with a network of financial institutions around the world to create a truly global community. Through their patent-pending SocialBoost ®, GlobeOne members collectively have the opportunity to earn an income stream from their banking relationships. In addition, they can instantly transfer funds domestically and internationally at no extra GlobeOne charge, establish a no-minimum demand checking account with debit card, and create a security / savings account with line of credit.
GlobeOne was founded by a community of entrepreneurs who recognize the potential of mobile technology to enable the world, for the first time ever, to have simple, affordable financial tools. Their mission is to create financial inclusion and financial opportunity for the growing number of dissatisfied and underserved by improving and enhancing their financial health and well-being.
About Acxiom
Acxiom is an enterprise data, analytics and software-as-a-service company that fuses trust, experience and scale to fuel data-driven results. For over 40 years, Acxiom has been an innovator in harnessing the most important sources and uses of data to strengthen connections between people, businesses and their partners. For more information about Acxiom, visit Acxiom.com . Acxiom is a registered trademark of Acxiom Corporation.
Contact:
Acxiom
Corporate Communications:
Ines Gutzmer, 404-434-0237
ines.gutzmer@acxiom.com
GACXM
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Yokogawa Collaborates with Shell on Robotics and AI Technology for Plant Maintenance18.6.2025 08:00:00 CEST | Press release
- Streamlining operations and reducing risk in asset integrity management – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has formalized a long-term agreement with Shell Global Solutions International B.V. (“Shell”) to integrate and further develop technologies for utilizing robots and drones in plant monitoring and maintenance. Under the agreement, Yokogawa will add an advanced machine vision tool called Operator Round by Exception (ORE), developed by Shell, into its own OpreX™ Robot Management Core. The enhanced software service will be made available by Yokogawa to customers in the energy, chemicals, and other industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617976629/en/ OpreX Robot Management Core ORE is a digital solution that uses machine vision and AI analytics to enable robots to autonomously perform a number of tasks in the operator round process, such as reading gauges and checking for
Ververica Announces Partnership with Aiven - Empowering Leading Enterprises to Create Value from their Data in Real-Time18.6.2025 08:00:00 CEST | Press release
Ververica, the original creators of Apache Flink® and a leader in stream processing technology, today announced a new partnership with Aiven, the AI-ready open source cloud data platform. This partnership enables Aiven to provide Ververica’s Unified Streaming Data Platform to their customers, expanding access to enterprise-grade streaming data capabilities for data-driven businesses around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617806011/en/ Ververica Announces Partnership with Aiven - Empowering Leading Enterprises to Create Value from their Data in Real-Time Under the partnership, Aiven customers can now unlock enterprise-grade stream processing with Ververica’s powerful platform — allowing them to make decisions and take actions at speed with data from any source — plus expert support from the original creators of Apache Flink. “This partnership is about removing friction and delivering real business
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years18.6.2025 07:00:00 CEST | Press release
An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV International Congress of Dermatology (ICD) found that Nemluvio was well tolerated and associated with sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, including both skin lesions and itch, up to two years1 Results build on data from OLYMPIA – the largest completed pivotal clinical program in prurigo nodularis and the only one assessing long-term safety and efficacy in prurigo nodularis1-3 This follows the presentation of data from the ARCADIA long-term extension study at the Revolutionizing Atopic Dermatitis (RAD) Conference earlier this month, which showed Nemluvio is well tolerated with sustained and increased improvements in efficacy outcomes in atopic dermatitis patients up to two years4 Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy o
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 06:30:00 CEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 03:30:00 CEST | Press release
Maximizing synergies to accelerate the global expansion of biometric info-driven government authentication and security business Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contr
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum